AHA yesterday submitted policy recommendations to House Ways and Means Committee leaders as they begin developing Medicare-related legislation to address the opioid crisis. The committee is seeking feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. AHA also has submitted recommendations to other committees of jurisdiction, as Congress plans to enact comprehensive legislation on opioids this spring. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote  that would have funded the government through Nov. 21. The CR was passed by…
Headline
The Healthcare Association of New York State Sept. 16 announced Bea Grause, R.N., its president and CEO, will retire in summer 2026. Grause was active for many…
Headline
The AHA submitted a statement Sept. 17 for a House Ways and Means Committee markup session on a series of health care and other bills. Specifically, the AHA…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The AHA Sept. 15 urged Aetna to rescind its recently announced “level of severity inpatient payment” policy, saying that it “could erode the transparency…